SCHEMBL1269552

SCHEMBL1269552

CCCCc1nc(NS(=O)(=O)c2ccc(C(F)(F)F)cc2Cl)ncc1Sc1ccc(S(=O)(=O)N2CCCCC2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ ATM Q13315 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ CCKBR P32239 1/20 0.38
▸ LMNA P02545 4/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ GAA P10253 6/20 0.36
▸ MAPT P10636 3/20 0.36
▸ NPSR1 Q6W5P4 3/20 0.36
▸ PPARG P37231 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ SCN9A Q15858 1/20 0.36
▸ PIK3C3 Q8NEB9 1/20 0.35
▸ HSD11B1 P28845 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269368 0.90 PTGDR (0.39) ALDH1A1L3MBTL1TSHRKMT2AMEN1
SCHEMBL1268625 0.90 ALDH1A1 (0.39) ALDH1A1L3MBTL1ATMTSHRKMT2A
SCHEMBL1269875 0.88 PTGDR (0.39) ALDH1A1L3MBTL1TSHRKMT2AMEN1
SCHEMBL1268542 0.88 ALDH1A1 (0.42) ALDH1A1L3MBTL1ATMTSHRKMT2A
SCHEMBL1268549 0.84 L3MBTL1 (0.42) ALDH1A1L3MBTL1TSHRKMT2AMEN1
SCHEMBL1269489 0.82 GAA (0.43) ALDH1A1L3MBTL1KMT2ALMNAGAA
SCHEMBL1269447 0.82 L3MBTL1 (0.41) ALDH1A1L3MBTL1TSHRKMT2AMEN1
SCHEMBL1269747 0.81 ALDH1A1 (0.42) ALDH1A1L3MBTL1ATMTSHRKMT2A
SCHEMBL1269704 0.80 GAA (0.46) ALDH1A1KMT2ALMNAGAAMAPT
SCHEMBL1269448 0.80 ALDH1A1 (0.52) ALDH1A1L3MBTL1TSHRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG ALDH1A1 2237/4885L3MBTL1 3486/4885ATM 3485/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG ALDH1A1 2237/4885L3MBTL1 3486/4885ATM 3485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback